Different types of amyloid concomitantly present in the same patients
Francesca Martini1, Gabriele Buda1, Vincenzo De Tata1
1Department of Clinical and Experimental Medicine, U.O. Hematology, University of Pisa, Italy.
Hematology Reports
|December 25, 2019
Summary
Simultaneous deposition of different amyloid types is rare but possible in plasma cell disorders. This study presents four cases, highlighting treatment challenges for elderly patients with systemic amyloidosis.
Area of Science:
- Hematology
- Pathology
- Biochemistry
Background:
- Concomitant deposition of different amyloid fibril types in a single patient is considered improbable.
- Amyloidosis, a group of diseases characterized by protein misfolding and deposition, presents diagnostic and therapeutic challenges.
Purpose of the Study:
- To report cases of biopsy-proven concomitant different types of amyloid fibrils in patients with plasma cell disorders.
- To discuss the therapeutic implications and challenges in managing frail, elderly patients with systemic amyloidosis.
Main Methods:
- Immunogold electron microscopy was used to characterize amyloid fibrils.
- Case series reporting clinical findings and treatment approaches.
Main Results:
- Four patients with plasma cell disorders were diagnosed with biopsy-proven concomitant different types of amyloid fibrils.
- Treatment decisions for elderly, frail patients involve balancing chemotherapy necessity for AL amyloidosis against treatment toxicity.
Conclusions:
- The co-occurrence of different amyloid types, though rare, should be considered in plasma cell disorder patients.
- Systemic amyloid syndromes necessitate therapy to prevent organ damage, with stem cell transplant as a preferred option for eligible candidates.
Keywords:
Amyloidosiscardiovascular diseaseelectron microscopymultiple myelomaplasma cell dyscrasiarenal diseaserheumatologic diseaseMore Related Videos
Related Concept Videos
Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
Amyloid Fibrils
6.2K
6.2K
Alzheimer's Disease: Overview
1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K


